drugset / Trial / NCT00029289
Effects of Lutein in Retinitis Pigmentosa
RandomizedCrossoverDouble-blindTreatment
Summary
Phase I/II double-masked, randomized, placebo-controlled, cross-over trial to determine effects of lutein on vision in retinitis pigmentosa, including safety and effective dosage assessment
Timeline
- Start
- 2001-04
- Primary completion
- —
- Completion
- 2002-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lutein | Other / unclassified | 30 mg | — |